Search

Displaying results 4681 - 4690 of 10000 in total
  1. Drug

    LGD-2226

    go.drugbank.com/drugs/DB08089
    Experimental

    An androgen receptor modulator.

  2. Drug

    Iopentol

    go.drugbank.com/drugs/DB13861
    Experimental

    Iopentol is used as a contrast medium.

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Prinaberel

    go.drugbank.com/drugs/DB06832
    Investigational

    Prinaberel is an estrogen receptor beta agonist.

  4. Drug

    AB192

    go.drugbank.com/drugs/DB06111
    Experimental

    AB192 is a DPP IV enzymatic activity inhibitor.

  5. Drug

    TO-901317

    go.drugbank.com/drugs/DB07080
    Experimental

    TO-901317 is an LXRalpha and LXRbeta agonist.

  6. Drug

    NCX 1022

    go.drugbank.com/drugs/DB05410
    Experimental

    NCX is an NO-releasing derivative of hydrocortisone.

  7. Drug

    HPA-23

    go.drugbank.com/drugs/DB17739
    Experimental

    HPA-23 is an investigational antiviral compound.[A259142]

  8. Drug

    Axitinib

    go.drugbank.com/drugs/DB06626
    ApprovedInvestigational

    [L6676] Axitinib is an indazole derivative.[A179398] It is most commonly marketed under the name Inlyta® and is available in oral formulations. … Axitinib is a second generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3).

    Synonyms: AR-14034Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
  9. Drug

    Human papillomavirus type 31 L1 capsid protein antigen

    go.drugbank.com/drugs/DB10310
    ApprovedInvestigational

    Human papillomavirus type 31 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. … It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 31.

  10. Drug

    OPC-51803

    go.drugbank.com/drugs/DB05838
    Experimental

    It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states. … OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist.